Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Cytovance(R) Biologics, Inc. Announces Manufacturing Agreement With Selexys Pharmaceuticals, Corp. for Phase II Production of SelG1

OKLAHOMA CITY, OK -- (Marketwire) -- 11/13/12 -- Cytovance® Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, announces an agreement with Selexys Pharmaceuticals, Corp. to produce its lead asset, the SelG1 monoclonal antibody (mAb) for a Phase II clinical study. A recent agreement with a major pharmaceutical company and the securing of Series A financing will allow Selexys to advance the SelG1 program through a large Phase II clinical study in patients with sickle cell disease.

Under the scope of this agreement, Cytovance Biologics will spearhead the cGMP manufacturing along with technical and regulatory support to supply the Selexys clinical program. SelG1 will be manufactured at the 1,000L scale in Cytovance's 44,000 sq. ft. production facility that was custom-designed for multi-product cGMP manufacturing and meets U.S. and EU regulatory standards.

"Cytovance continues to be an integral part of our efforts at Selexys and has played a key role in the advancement of our clinical programs. We look forward to working with Cytovance on this important project as well as other projects in the future," said Dr. Scott Rollins, President and CEO of Selexys.

"Cytovance shares in Selexys' enthusiasm for the future of SelG1," stated Darren Head, President and Chief Executive Officer of Cytovance Biologics. "The recent news and potential of this product highlighted by the growing partnership between Cytovance and Selexys -- both Oklahoma companies -- is a representation of the well-built biotech community in Oklahoma."

Cytovance originally collaborated with Selexys Pharmaceuticals in 2010 to develop and manufacture its Anti-PSGL-1 therapeutic agent, a monoclonal antibody (mAb) developed for treatment of inflammation associated with Crohn's disease.

About Cytovance® Biologics

Cytovance® Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. In addition to its cGMP manufacturing services, the company offers process development, cGMP cell banking and support services from its Oklahoma City state-of-the-art facilities. Learn more about Cytovance Biologics at www.cytovance.com.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Media Contact:
Jodie Gutkowski
Marketing Communications Manager
Email Contact

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
The notion of improving operational efficiency is conspicuously absent from the healthcare debate - neither Obamacare nor the newly proposed GOP plan discusses the impact that a step-function improvement in efficiency could have on access to healthcare (through more capacity), quality ...
In 2011, Marc Andreessen wrote a thought provoking article in the Wall Street Journal that software is eating the world. Today, in 2017, we can say that cloud transformation is happening all around us and cloud is now indeed eating the world. While Cloud services consumption is becomin...
Thanks to the plethora of communication and messaging apps available to the average user, unified communications (UC) is becoming more important than ever before. UC is a set of products and services designed to give employees a uniform communications experience, integrating different ...
Cloud providers like AWS have proven to be a viable option for running mainframe application workloads. The most effective method to exploit the value of Unisys mainframe applications and data is a transformative migration to modern systems frameworks in AWS, reusing as much of the ori...
Having a well-rounded brand strategy helps you identify the marketing channels you must focus on, and defines every aspect of how your business is viewed by your customers. Marketing and advertising is an integral component of every business. The US Small Business Administration reco...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE